ClinicalTrials.gg
Sign In

Dementia, Vascular clinical trials

The registry lists 183 studies for Dementia, Vascular across more than 10 countries. 44 are recruiting or about to start. 36 of them are mainly about Dementia, Vascular (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-03. Counting its narrower condition CADASIL too: 213 studies, 60 open.

Get an email when these change. Save the Dementia, Vascular studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
92
Recruiting
36
Status unknown
31
Active, not recruiting
10
Terminated
5
Not yet recruiting
4

Phase

Phase 3
24
Phase 2
23
Phase 4
7
Phase 1
5

Where

United States
65
China
19
United Kingdom
12
Germany
10
Canada
8
Australia
7

Who runs them

Hopeful Aging (6) · University of Pennsylvania (5) · Dongzhimen Hospital, Beijing (5) · University of California, San Francisco (4) · University Health Network, Toronto (4) · Eisai Inc. (3) · National Taiwan University Hospital (3) · University College, London (3)

What is being tested here

Drugs under test in Dementia, Vascular studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pittsburgh compound B101
Cannabidiol111
Dapagliflozin111
Donepezil024
Galantamine033
Risperidone033
Rivastigmine022
Telmisartan012
Atorvastatin001
Urolithin A Supplement001

Drug classes tested here Cholinesterase inhibitors 9 · Antipsychotics 5

Coming up

3phase 3 studies under way
14studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 36 Dementia, Vascular studies recruiting now, 26 (72%) set no upper age limit and 2 (6%) stop at 75 or younger. 4 (11%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 14 (39%) take healthy volunteers.

Recruiting studies that take each age, of 36
AgeWomenMen
104 (11%)4 (11%)
1818 (50%)18 (50%)
3020 (56%)20 (56%)
4021 (58%)21 (58%)
5027 (75%)27 (75%)
6536 (100%)36 (100%)
7535 (97%)35 (97%)
8531 (86%)31 (86%)

Across all 183 studies, recruiting or not: 5% stop at 75 or younger and 1% at 65; 6% take children; 1% are for women only and 0% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Dementia, Vascular studies take

Of 52 interventional studies with no phase under Dementia, Vascular, half reached primary completion within 35 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase35 mo25–53 · 52 studies—36 mo26–53 · 42 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 183. Browse all 183 → or search them.